Bessemer Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-737
Closed -$37K 2777
2024
Q4
$37K Sell
737
-1,903
-72% -$93.5K ﹤0.01% 1340
2024
Q3
$109K Buy
2,640
+201
+8% +$9.65K ﹤0.01% 1270
2024
Q2
$118K Hold
2,439
﹤0.01% 1138
2024
Q1
$117K Buy
2,439
+344
+16% +$18.4K ﹤0.01% 1148
2023
Q4
$136K Buy
2,095
+339
+19% +$20.4K ﹤0.01% 1138
2023
Q3
$114K Buy
1,756
+61
+4% +$3.84K ﹤0.01% 1163
2023
Q2
$99K Buy
1,695
+186
+12% +$11.7K ﹤0.01% 1227
2023
Q1
$93K Buy
+1,509
New +$90.5K ﹤0.01% 1099
2022
Q4
Sell
-40
Closed -$3K 2181
2022
Q3
$3K Buy
+40
New +$2.98K ﹤0.01% 1882

Other funds holding NARI

Bessemer Group's NARI Position: Q1 2025 in Review

Bessemer Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 737 shares — an estimated $37K sold.

Bessemer Group first reported a position in NARI in Q3 2022 and held it in 9 quarters. The position peaked at $136K in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bessemer Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bessemer Group sold 737 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $37K.
  • Bessemer Group first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 9 quarters.
  • Bessemer Group's Inari Medical, Inc. Common Stock position peaked at $136K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bessemer Group's 13F filing for Q1 2025, filed 23 Apr 2025.